
1. Technology overview
Time is Brain is a medical device company located at Recinte Modernista Sant Pau, Barcelona, Spain. It was founded in 2020 as a spin-off from the Germans Trias i Pujol Research Institute by three neurologists, and focuses on stroke care.
BraiN20 is a tablet-sized, portable, non-invasive bedside device that monitors neurological function in real time using the N20 biomarker, described as an indicator of salvageable brain tissue. It is fully automatic and can be used in the emergency room, operating room and ICU. The company announced CE/MDR approval in July 2026 and plans a European rollout through distributors.
2. Highlighted features & specifications
- N20 biomarker: monitors a signal linked to salvageable brain tissue.
- Portable: tablet-sized device for bedside use.
- Fully automatic: no specialist training required.
- Emergency room use: quick brain function assessment on arrival.
- Operating room use: intraoperative monitoring during thrombectomy and neurosurgery.
- ICU use: continuous monitoring of sedated or anesthetized patients.
3. Potential application
Emergency departments in Vietnamese provincial hospitals can use it for rapid assessment of suspected stroke. Neurointerventional teams can monitor patients during thrombectomy. ICUs can track neurological status of sedated patients.
4. Benefits
Gives real-time brain function data at the bedside to support treatment decisions. Complements imaging when imaging is limited or delayed. Can be used by any clinician without specialist training. The company reports validation in more than 200 patients.
5. Market trends & opportunities
Stroke care is shifting toward faster, data-driven decisions, with the company citing more than 10 million strokes worldwide each year. Vietnamese hospitals expanding stroke units and thrombectomy programs need bedside tools that work where advanced imaging is limited.
6. Other information
Spin-off of the Germans Trias i Pujol Research Institute, Barcelona. EIC Accelerator grant for BraiN20 reported by EIT Health in January 2023 (third-party source). CE/MDR approval and 3 million EUR pre-Series A announced 10 July 2026; European distributor onboarding planned. EIT Health Catapult 2023 winner.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































